Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors and the Risk of Fracture: A Systematic Review and Meta-analysis of Randomized Controlled Trials-Reference-Cited by-同舟云学术

Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors and the Risk of Fracture: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Published:2023-04-26 Issue:2 Volume:113 Page:175-185
ISSN:1432-0827
Container-title:Calcified Tissue International
language:en
Short-container-title:Calcif Tissue Int

Author:

Lv Fang,Cai Xiaoling^ORCID,Lin Chu,Yang Wenjia,Hu Suiyuan,Ji Linong^ORCID

Funder

National Natural Science Foundation of China

Natural Science Foundation of Beijing Municipality

Peking University People's Hospital Research and Development Funds

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

https://link.springer.com/content/pdf/10.1007/s00223-023-01085-0.pdf

Reference33 articles.

1. Consensus development conference (1993) diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 94(6):646–650. https://doi.org/10.1016/0002-9343(93)90218-e

2. Blake J et al. (2021) Management of osteoporosis in postmenopausal women: the 2021 position statement of the North American menopause society’’ editorial panel. Management of osteoporosis in postmenopausal women: the 2021 position statement of the North American menopause society. Menopause 28(9):973–997

3. Pelton K, Krieder J, Joiner D, Freeman MR, Goldstein SA, Solomon KR (2012) Hypercholesterolemia promotes an osteoporotic phenotype. Am J Pathol 181(3):928–936. https://doi.org/10.1016/j.ajpath.2012.05.034

4. Orozco P (2004) Atherogenic lipid profile and elevated lipoprotein (a) are associated with lower bone mineral density in early postmenopausal overweight women. Eur J Epidemiol 19(12):1105–1112. https://doi.org/10.1007/s10654-004-1706-8

5. Kim J, Ha J, Jeong C, Lee J, Lim Y, Jo K, Kim MK, Kwon HS, Song KH, Baek KH (2022) Bone mineral density and lipid profiles in older adults: a nationwide cross-sectional study. Osteoporos Int. https://doi.org/10.1007/s00198-022-06571-z

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PCSK9 inhibitors and inclisiran with or without statin therapy on incident muscle symptoms and creatine kinase: a systematic review and network meta-analysis;Frontiers in Cardiovascular Medicine;2024-07-08

2. Association of statin use with osteoporosis risk: a drug-targeted Mendelian randomization study;Inflammopharmacology;2024-02-16

3. Biologics: Teriparatide and Newer Anabolics;Indian Journal of Orthopaedics;2023-11-29